Similar Articles

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 257

Cervicogenic Headache

Levent Ertuğrul İNAN, Harika MIHOĞLU

Issue: 1996, Volume 2 - Issue 1-2
0 242

Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.

Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA

Issue: 1995, Volume 1 - Issue 3
0 227

Anxiety and Depression in Chronic Headache

Deniz SELÇUKİ, Canan YÜCESAN, Nermin MUTLUER, Rana TANRIDAĞ, Gönül OZAN

Issue: 1995, Volume 1 - Issue 3
0 296

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 276

Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN

Issue: 1995, Volume 1 - Issue 1
0 254

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 317

The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study

Emir Ruşen, Gaye Hafez, Yeşim Tunç

DOI: 10.55697/tnd.2024.18

Issue: 2024, Volume 30 - Issue 1
1643 781

Could pulsed radiofrequency stimulation of the proximal greater occipital nerve be a treatment option for refractory chronic migraine patients?

Derya Yavuz Demiray, Ferhat Ege

DOI: 10.55697/tnd.2024.1

Issue: 2024, Volume 30 - Issue 4
698 480

The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment

Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil

DOI: 10.55697/tnd.2025.216

Issue: 2025, Volume 31 - Issue 1
241 160